Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteop...
Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial
About this item
Full title
Author / Creator
Kendler, David L , Marin, Fernando , Zerbini, Cristiano A F , Russo, Luis A , Greenspan, Susan L , Zikan, Vit , Bagur, Alicia , Malouf-Sierra, Jorge , Lakatos, Péter , Fahrleitner-Pammer, Astrid , Lespessailles, Eric , Minisola, Salvatore , Body, Jean Jacques , Geusens, Piet , Möricke, Rüdiger and López-Romero, Pedro
Publisher
England: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
No clinical trials have compared osteoporosis drugs with incident fractures as the primary outcome. We compared the anti-fracture efficacy of teriparatide with risedronate in patients with severe osteoporosis.
In this double-blind, double-dummy trial, we enrolled post-menopausal women with at least two moderate or one severe vertebral fracture a...
Alternative Titles
Full title
Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_hal_primary_oai_HAL_hal_03310878v1
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_03310878v1
Other Identifiers
ISSN
0140-6736
E-ISSN
1474-547X
DOI
10.1016/S0140-6736(17)32137-2
